Wednesday, July 6, 2022
Home Tags APHX

Tag: APHX

Video

Kevin Harrington Presentation. (Video)

Editor / Curator -
Mark Washo, Aphex Biocleanse
CoronaVirus

Aphex BioCleanse Systems Appoints Respected Marketing Veteran Mark Washo as Senior...

Editor / Curator -
Superbug News - CoronaVirus Watch List

Shark Tanks’ Kevin Harrington Gets Into Sanitizer Business.

Editor / Curator -
aPHEX bIOcLEANSE
Superbug News - CoronaVirus Watch List

Hy-IQ Trademark

Editor / Curator -
Superbug News - CoronaVirus Watch List

Clorox and P&G Struggle to Meet COVID-19-Related Spike in Demand (MarketWatch).

Editor / Curator -
Alpex BioCleanse, Biotech Stock Review
Superbug News - CoronaVirus Watch List

Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now...

Editor / Curator -
Biotech Stock Review
Superbug News - CoronaVirus Watch List

Regular Old Flu, Kills 290,000 to 650,000 a Year.

Editor / Curator -
Biotech Stock Review
Superbug News - CoronaVirus Watch List

Coronavirus Stocks Still on a Tear.

Editor / Curator -
Aphex Biocleanse, Superbug Stock Review
All News

Oh, No. Alcohol-Based Sanitizers Losing Effectiveness Against Superbugs.

Editor / Curator -

Latest article

Smart for Life (SMFL) Capitulates?

Client Editor / Curator -
We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Biotech News Editor / Curator -
Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

Bitcoin Editor / Curator -
Great call. This was actually from Late 2018. (Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.